drugset / Trial / NCT04561921
Effect of Magnesium Sulphate Added to Mepivacaine Hydrochloride on Inferior Alveolar Nerve Block Success in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars: A Randomized Clinical Trial.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
the study is conducted to assess the effect of adding magnesium sulphate to mepivacaine HCl compared to mepivacaine HCl alone on the success of inferior alveolar nerve block in patients with symptomatic irreversible pulpitis in mandibular molars
Timeline
- Start
- 2020-10-22
- Primary completion
- 2021-10-01
- Completion
- 2021-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 0.18 ml | Other |
| Subject | Magnesium Sulfate | Other / unclassified | 10 % | Other |
| Comparator | Levonordefrin | Small molecule | 0.06 mg | Other |
| Comparator | Mepivacaine | Other / unclassified | 1.8 ml | Other |
| Comparator | Mepivacaine | Other / unclassified | 2 % | Other |
Indications
No indication recorded.